TCD PHARMA
Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the future of Oncology by developing innovative therapies that address unmet medical needs. Established in 2005 and with one product, TCD-717, already in clinical trials the Company is positioning itself as Spain’s Partner of Choice for Oncology drug discovery and development opportunities. TCD’s strong management team, its strategy of building its pipeline through in-licensing and partnerships and by leveraging resources through collaborations and outsourcing via premier Contract Research Organizations, allows TCD to be in the forefront of Oncology drug development while significantly lowering risks and costs.
TCD PHARMA
Industry:
Biotechnology Medical
Founded:
2005-01-01
Address:
Madrid, Madrid, Spain
Country:
Spain
Website Url:
http://www.tcdpharma.com
Total Employee:
1+
Status:
Active
Contact:
34 983 10 20 50
Email Addresses:
[email protected]
Total Funding:
10.86 M USD
Technology used in webpage:
Nginx Euro OpenSSL Unix Baidu Analytics Mod_ssl DAV OpenSSL 0.9.8 Peg Technic Baidu Cloud
Similar Organizations
Actelion Pharmaceuticals
Actelion Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of low molecular weight drugs for
Bionostra
Bionostra is engaged in the R&D and commercialization of biotechnology services.
Roche Glycart
Roche Glycart is a biotechnology company, engages in the research, development, and commercialization of antibody-based products.
Morvus Technology
Morvus Technology engages in the discovery, development, and commercialization of drugs and technologies in the oncology field.
Reset Pharmaceuticals
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Current Advisors List
Current Employees Featured
Investors List
CRB InverbÃo
CRB InverbÃo investment in Series B - TCD Pharma
Clave Mayor
Clave Mayor investment in Series A - TCD Pharma
S.G.E.C.R.
S.G.E.C.R. investment in Series A - TCD Pharma
CRB InverbÃo
CRB InverbÃo investment in Series A - TCD Pharma
